These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 26136615)

  • 1. HULC and H19 Played Different Roles in Overall and Disease-Free Survival from Hepatocellular Carcinoma after Curative Hepatectomy: A Preliminary Analysis from Gene Expression Omnibus.
    Yang Z; Lu Y; Xu Q; Tang B; Park CK; Chen X
    Dis Markers; 2015; 2015():191029. PubMed ID: 26136615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma.
    Yan TH; Yang H; Jiang JH; Lu SW; Peng CX; Que HX; Lu WL; Mao JF
    Int J Clin Exp Pathol; 2015; 8(4):4126-31. PubMed ID: 26097602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum long noncoding RNA urothelial carcinoma-associated 1: A novel biomarker for diagnosis and prognosis of hepatocellular carcinoma.
    Zheng ZK; Pang C; Yang Y; Duan Q; Zhang J; Liu WC
    J Int Med Res; 2018 Jan; 46(1):348-356. PubMed ID: 28856933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Up-regulation of miR-9 expression predicate advanced clinicopathological features and poor prognosis in patients with hepatocellular carcinoma.
    Cai L; Cai X
    Diagn Pathol; 2014 Dec; 9():1000. PubMed ID: 25552204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy.
    Yuan SX; Yang F; Yang Y; Tao QF; Zhang J; Huang G; Yang Y; Wang RY; Yang S; Huo XS; Zhang L; Wang F; Sun SH; Zhou WP
    Hepatology; 2012 Dec; 56(6):2231-41. PubMed ID: 22706893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long non-coding RNA CARLo-5 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.
    Wang F; Xie C; Zhao W; Deng Z; Yang H; Fang Q
    Clin Exp Med; 2017 Feb; 17(1):33-43. PubMed ID: 26433964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of long noncoding RNA and c-JUN expression in hepatocellular carcinoma.
    El-Tawdi AH; Matboli M; El-Nakeep S; Azazy AE; Abdel-Rahman O
    Expert Rev Gastroenterol Hepatol; 2016 Jul; 10(7):869-77. PubMed ID: 27215316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progress and Prospects of Long Noncoding RNAs (lncRNAs) in Hepatocellular Carcinoma.
    Li C; Chen J; Zhang K; Feng B; Wang R; Chen L
    Cell Physiol Biochem; 2015; 36(2):423-34. PubMed ID: 25968300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and prognostic significance of vascular endothelial growth factor receptor 1 in hepatocellular carcinoma.
    Li T; Zhu Y; Qin CY; Yang Z; Fang A; Xu S; Ren W
    J Clin Pathol; 2012 Sep; 65(9):808-14. PubMed ID: 22734007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long non-coding RNA PANDAR correlates with poor prognosis and promotes tumorigenesis in hepatocellular carcinoma.
    Peng W; Fan H
    Biomed Pharmacother; 2015 May; 72():113-8. PubMed ID: 26054684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical contribution to recurrence-free survival in patients with macrovascular-invasion-negative hepatocellular carcinoma.
    Tanaka S; Mogushi K; Yasen M; Noguchi N; Kudo A; Kurokawa T; Nakamura N; Inazawa J; Tanaka H; Arii S
    J Am Coll Surg; 2009 Mar; 208(3):368-74. PubMed ID: 19317998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The beta2-adrenergic receptor is a potential prognostic biomarker for human hepatocellular carcinoma after curative resection.
    Chen D; Xing W; Hong J; Wang M; Huang Y; Zhu C; Yuan Y; Zeng W
    Ann Surg Oncol; 2012 Oct; 19(11):3556-65. PubMed ID: 22588469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of long noncoding RNAs biomarkers in patients with hepatitis B virus-associated hepatocellular carcinoma.
    Mou Y; Wang D; Xing R; Nie H; Mou Y; Zhang Y; Zhou X
    Cancer Biomark; 2018; 23(1):95-106. PubMed ID: 29991128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Value of Long Non-Coding RNA HULC and MALAT1 Following the Curative Resection of Hepatocellular Carcinoma.
    Sonohara F; Inokawa Y; Hayashi M; Yamada S; Sugimoto H; Fujii T; Kodera Y; Nomoto S
    Sci Rep; 2017 Nov; 7(1):16142. PubMed ID: 29170515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SNHG3 correlates with malignant status and poor prognosis in hepatocellular carcinoma.
    Zhang T; Cao C; Wu D; Liu L
    Tumour Biol; 2016 Feb; 37(2):2379-85. PubMed ID: 26373735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of matrix metalloproteinase-12 (MMP-12) correlates with poor prognosis of hepatocellular carcinoma.
    Ng KT; Qi X; Kong KL; Cheung BY; Lo CM; Poon RT; Fan ST; Man K
    Eur J Cancer; 2011 Oct; 47(15):2299-305. PubMed ID: 21683576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of APOBEC3F in tumor tissues is potentially predictive for poor recurrence-free survival from HBV-related hepatocellular carcinoma.
    Yang Z; Zhuang L; Yu Y; Zhou W; Lu Y; Xu Q; Tang B; Chen X
    Discov Med; 2015 Dec; 20(112):349-56. PubMed ID: 26760979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA NEAT1 overexpression is associated with unfavorable prognosis in patients with hepatocellular carcinoma after hepatectomy: A Chinese population-based study.
    Liu Z; Chang Q; Yang F; Liu B; Yao HW; Bai ZG; Pu CS; Ma XM; Yang Y; Wang TT; Guo W; Zhou XN; Zhang ZT
    Eur J Surg Oncol; 2017 Sep; 43(9):1697-1703. PubMed ID: 28732670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of long non-coding RNA MINCR contributes to progressive clinicopathological features and poor prognosis of human hepatocellular carcinoma.
    Jin XL; Lian JR; Guan YH
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8197-8202. PubMed ID: 30556858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma HULC as a promising novel biomarker for the detection of hepatocellular carcinoma.
    Xie H; Ma H; Zhou D
    Biomed Res Int; 2013; 2013():136106. PubMed ID: 23762823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.